Taysha Gene Therapies, Inc.
TSHA
Revenue
1.99M
▼-316.00k▼-13.73%
3 Months ChangeAssets
333.33M
▲194.97M▲140.91%
3 Months ChangeLiabilities
84.60M
▲1.30M▲1.56%
3 Months ChangeFree Cash Flow
-19.94M
▲4.15M▲17.22%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0000950170-24-095082
2024-08-12
Form 8-K
ID: 0001193125-24-198392
2024-06-26
Form 8-K
ID: 0001193125-24-169191
2024-06-26
Form 8-K
ID: 0001193125-24-168479
2024-06-18
Form 8-K
ID: 0001193125-24-163050
2024-05-30
Form 8-K
ID: 0001193125-24-150323
2024-05-14
Form 8-K
ID: 0001193125-24-138253
2024-05-14
Form 10-Q
ID: 0000950170-24-059555
2024-03-19
Form 8-K
ID: 0001193125-24-071321
2024-01-10
Form 8-K
ID: 0001193125-24-005637